Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Chooses Lark's In-House Service Lab

Premium

HOUSTON--Lark Technologies has finalized an agreement with Pfizer to establish an in-house contract service laboratory focused on providing high-quality, fast-turnaround DNA sequencing services for Pfizer. Lark will provide the services in a laboratory exclusively dedicated to meeting the DNA sequencing requests of Pfizer at its UK facility in Sandwich.

Lark will work on behalf of Pfizer for specified fees on a no-rights-retained, contract basis. Lark said the deal is attractive for companies like Pfizer that have multiple project needs and require a consistent and reliable flow of high-quality DNA sequence information.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.